Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mid-Infrared Spectroscopy for the Qualitative and Quantitative Analysis of the Wheat Proteome.

Analytical chemistry·2026
Same author

MicroRNA-26b protects against MASH development in mice and can be efficiently targeted with lipid nanoparticles.

eLife·2025
Same author

Inhibition of intracellular versus extracellular cathepsin D differentially alters the liver lipidome of mice with metabolic dysfunction-associated steatohepatitis.

The FEBS journal·2024
Same author

The Modulatory Effects of Fatty Acids on Cancer Progression.

Biomedicines·2023
Same author

A Transient Inflammatory Response Induced by Lipopolysaccharide Infusion Lowers Markers of Endogenous Cholesterol and Bile Acid Synthesis in Healthy Normocholesterolemic Young Men.

Biomedicines·2023
Same author

Potential for Omega-3 Fatty Acids to Protect against the Adverse Effect of Phytosterols: Comparing Laboratory Outcomes in Adult Patients on Home Parenteral Nutrition Including Different Lipid Emulsions.

Biology·2022

Related Experiment Video

Updated: Oct 9, 2025

Engineering and Characterization of an Optogenetic Model of the Human Neuromuscular Junction
11:07

Engineering and Characterization of an Optogenetic Model of the Human Neuromuscular Junction

Published on: April 14, 2022

2.5K

NASH and Systemic Complications: From Basic to Clinical Research.

Sabine Baumgartner1, Ronit Shiri-Sverdlov2

  • 1Department of Nutrition and Movement Sciences, School of Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University, Universiteitssingel 50, 6229 ER Maastricht, The Netherlands.

Biomedicines
|December 24, 2021
PubMed
Summary

Nonalcoholic fatty liver disease (NAFLD) is a liver condition linked to metabolic syndrome. While many cases involve simple fat accumulation, a significant portion can progress to nonalcoholic steatohepatitis (NASH).

More Related Videos

Nutrient Regulation by Continuous Feeding for Large-scale Expansion of Mammalian Cells in Spheroids
11:01

Nutrient Regulation by Continuous Feeding for Large-scale Expansion of Mammalian Cells in Spheroids

Published on: September 25, 2016

7.8K
Detection of Nitric Oxide and Superoxide Radical Anion by Electron Paramagnetic Resonance Spectroscopy from Cells using Spin Traps
13:21

Detection of Nitric Oxide and Superoxide Radical Anion by Electron Paramagnetic Resonance Spectroscopy from Cells using Spin Traps

Published on: August 18, 2012

19.1K

Related Experiment Videos

Last Updated: Oct 9, 2025

Engineering and Characterization of an Optogenetic Model of the Human Neuromuscular Junction
11:07

Engineering and Characterization of an Optogenetic Model of the Human Neuromuscular Junction

Published on: April 14, 2022

2.5K
Nutrient Regulation by Continuous Feeding for Large-scale Expansion of Mammalian Cells in Spheroids
11:01

Nutrient Regulation by Continuous Feeding for Large-scale Expansion of Mammalian Cells in Spheroids

Published on: September 25, 2016

7.8K
Detection of Nitric Oxide and Superoxide Radical Anion by Electron Paramagnetic Resonance Spectroscopy from Cells using Spin Traps
13:21

Detection of Nitric Oxide and Superoxide Radical Anion by Electron Paramagnetic Resonance Spectroscopy from Cells using Spin Traps

Published on: August 18, 2012

19.1K

Area of Science:

  • Hepatology
  • Metabolic Disorders
  • Gastroenterology

Background:

  • Nonalcoholic fatty liver disease (NAFLD) is recognized as the liver manifestation of metabolic syndrome.
  • While most individuals with NAFLD present with simple steatosis, a substantial subset, up to one-third, may progress to nonalcoholic steatohepatitis (NASH).

Discussion:

  • The progression from simple steatosis to NASH involves inflammation and liver cell injury.
  • Understanding the factors driving this progression is crucial for effective management and treatment strategies.
  • NAFLD and NASH represent a growing global health concern due to their association with obesity and type 2 diabetes.

Key Insights:

  • NAFLD is a spectrum of liver conditions, not a single entity.
  • Progression to NASH signifies a more severe form of the disease with higher risks.
  • Early identification and intervention are key to preventing advanced liver damage.

Outlook:

  • Further research is needed to elucidate the precise mechanisms of NAFLD progression to NASH.
  • Development of targeted therapies for NASH is a priority in liver disease research.
  • Long-term monitoring and lifestyle interventions remain critical for managing NAFLD patients.